Risk of Venous Thromboembolism in Non-Hodgkin Lymphoma patients surviving Blood or Marrow Transplantation

BACKGROUND: Patients with non-Hodgkin lymphoma (NHL) have increased risk of venous thromboembolism (VTE), particularly when receiving treatment. Blood or marrow transplantation (BMT) is recommended for relapsed/refractory NHL, and the risk of VTE after they undergo BMT is uncertain. METHODS: We surv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Gangaraju, Radhika, Chen, Yanjun, Hageman, Lindsey, Wu, Jessica, Francisco, Liton, Kung, Michelle, Ness, Emily, Parman, Mariel, Weisdorf, Daniel J., Forman, Stephen J., Arora, Mukta, Armenian, Saro H., Bhatia, Smita
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6891120/
https://ncbi.nlm.nih.gov/pubmed/31469420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32488
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados